LianBio

LianBioverified

LIAN

Price:

$0.319

Market Cap:

$34.47M

LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with preserved ejection fraction; TP-03 for the treatment of Demodex blepharitis; NBTXR3 for the treatment of head and neck squamous cell carcinoma, and solid tumor; Infigratinib for the treatment of second-line and first-line cholangiocarcinoma, and gastric cancers; BBP-398 for solid tumors; Omilancor for ulcerative colitis and Crohn's disease; NX-13 for u...[Read more]

Industry

Biotechnology

IPO Date

2021-11-01

Stock Exchange

NASDAQ

Ticker

LIAN

The Enterprise Value as of December 2024 (TTM) for LianBio (LIAN) is -66141903.00

According to LianBio’s latest financial reports and current stock price. The company's current Enterprise Value is -66141903.00. This represents a change of -163.49% compared to the average of 104.18M of the last 4 quarters.

LianBio (LIAN) Historical Enterprise Value (quarterly & annually)

How has LIAN Enterprise Value performed in the past?

The mean historical Enterprise Value of LianBio over the last ten years is 680.30M. The current -66141903.00 Enterprise Value has changed -1072.25% with respect to the historical average. Over the past ten years (40 quarters), LIAN's Enterprise Value was at its highest in in the September 2021 quarter at 1.33B. The Enterprise Value was at its lowest in in the September 2020 quarter at 0.

Quarterly (TTM)
Annual

Average

680.30M

Median

645.83M

Minimum

-11477128.48

Maximum

1.44B

LianBio (LIAN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of LianBio Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Enterprise Value = 1.44B

Minimum Annual Increase = -989.70%

Minimum Annual Enterprise Value = -11477128.48

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2022102.11M-989.70%
2021-11477128.48-100.96%
20201.19B-17.45%

LianBio (LIAN) Average Enterprise Value

How has LIAN Enterprise Value performed in the past?

The current Enterprise Value of LianBio (LIAN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

426.73M

5-year avg

680.30M

10-year avg

680.30M

LianBio (LIAN) Enterprise Value vs. Peers

How is LIAN’s Enterprise Value compared to its peers?

LianBio’s Enterprise Value is less than Sensei Biotherapeutics, Inc. (-3035508.00), less than NextCure, Inc. (4.85M), less than Nuvation Bio Inc. (889.92M), less than Graphite Bio, Inc. (-15007658.00), less than Merrimack Pharmaceuticals, Inc. (-10189682.00), less than Inozyme Pharma, Inc. (208.51M), less than Day One Biopharmaceuticals, Inc. (849.50M), less than Terns Pharmaceuticals, Inc. (218.72M), less than Eledon Pharmaceuticals, Inc. (246.45M), less than HOOKIPA Pharma Inc. (-39184866.00), less than Fennec Pharmaceuticals Inc. (160.46M), less than Larimar Therapeutics, Inc. (209.57M), less than Verrica Pharmaceuticals Inc. (86.82M), greater than Homology Medicines, Inc. (-103303255.00), less than Neoleukin Therapeutics, Inc. (-6333315.00), less than Instil Bio, Inc. (217.29M), less than Achilles Therapeutics plc (-35783455.00), less than Assembly Biosciences, Inc. (68.65M), less than Acumen Pharmaceuticals, Inc. (103.75M),

Build a custom stock screener for LianBio (LIAN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like LianBio using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

LianBio (LIAN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like LianBio or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is LianBio's Enterprise Value?

What is the highest Enterprise Value for LianBio (LIAN)?

What is the 3-year average Enterprise Value for LianBio (LIAN)?

What is the 5-year average Enterprise Value for LianBio (LIAN)?

How does the current Enterprise Value for LianBio (LIAN) compare to its historical average?